2026 NPPES data Oncology Pharmacist NPI 1144599648 PHARMD
Verify on CMS →

ANDREW LIN, PHARMD

Oncology Pharmacist in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
56
Medicare Part D claims · 21 beneficiaries · Oncology Pharmacist avg: 160
What the federal data reveals: ANDREW LIN, PHARMD is a Oncology Pharmacist ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 56 claims across 21 beneficiaries .

What stands out: ANDREW LIN, PHARMD filed 56 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ANDREW LIN, PHARMD at a glance

Quality data not reported

NPI registry status

Active

Issued 12/29/2011

NPI 1144599648

Primary specialty

Oncology Pharmacist

Niche

1,699 US NPIs in this specialty

Medicare Part D claims

56 65% vs specialty avg

2023 prescription claims

Specialty avg: 160

Specialty distribution in New York

How Oncology Pharmacist compares to other specialties among New York providers

New York providers

Oncology Pharmacist share within New York

1. Oncology Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Pharmacist share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Pharmacist ABMS/AOA estimate

Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANDREW LIN, PHARMD is a Oncology Pharmacist provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARMD. NPI: 1144599648. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ANDREW LIN, PHARMD appears in the CMS NPPES registry as a Oncology Pharmacist provider holding PHARMD credentials at 1275 YORK AVE, NEW YORK, NY, 10065, with a listed phone of (212) 639-3802. NPI 1144599648 was issued on 12/29/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 56 prescription claims written by this provider, covering 21 Medicare beneficiaries and totaling roughly $51K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oncology Pharmacist is a narrow specialty nationwide, with 1,699 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1275 YORK AVE
NEW YORK, NY 10065

Provider Details

NPI 1144599648
Specialty Oncology Pharmacist
Credentials PHARMD
Gender Male
NPI Issued 12/29/2011

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ANDREW LIN, PHARMD. To verify ANDREW LIN, PHARMD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

56
Total Claims
$51K
Total Drug Cost
21
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
57
Total Day Supply
1,444
Generic Drug Cost
$7K

Patient Demographics

Average Patient Age
70.6 years
Avg HCC Risk Score
3.13

Oncology Pharmacist Overview

How ANDREW LIN, PHARMD fits within the Oncology Pharmacist landscape nationally.

1,699
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider

ANDREW LIN, PHARMD's 56 claims are below the specialty average of 160.

Nearby Oncology Pharmacist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as LIN.

Compare Oncology Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANDREW LIN, PHARMD's specialty?
ANDREW LIN, PHARMD specializes in Oncology Pharmacist and practices in NEW YORK, New York. Credentials: PHARMD.
How much does ANDREW LIN, PHARMD prescribe under Medicare Part D?
In 2023, ANDREW LIN, PHARMD wrote 56 Medicare Part D claims totaling $51K in drug costs for 21 beneficiaries.
Where is ANDREW LIN, PHARMD located?
ANDREW LIN, PHARMD is located at 1275 YORK AVE, NEW YORK, NY, 10065. Phone: (212) 639-3802.
What is ANDREW LIN, PHARMD's NPI number?
ANDREW LIN, PHARMD's National Provider Identifier (NPI) is 1144599648, issued on 12/29/2011.
How many Oncology Pharmacist providers are there in the US?
There are 1,699 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
Does ANDREW LIN, PHARMD accept Medicare?
ANDREW LIN, PHARMD appears in CMS Medicare data with 56 Part D claims and 21 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANDREW LIN, PHARMD's credentials?
ANDREW LIN, PHARMD's NPI is 1144599648 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology